Closed
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Sale
Calculated transaction value
$147.61K

Rothblatt Martine A Chairperson & CEO

Transaction date Jul 15, 2026
Public filing date Jul 16, 2026
Filing lag Filed 1 day later

UTHR daily price context

Close on/before transaction
$531.79 Jul 15, 2026
First close after public filing
$535.67 Jul 17, 2026
30-day return after filing
-5.08% Through Aug 17, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
278 shares @ $530.97
SEC ownership
Direct
Transaction code
S
Form
4
Filing identifier
0001106578-26-000099
Filing cohort

Transactions in this filing

Showing 15 of 25
Trades
25
Issuers
1
Estimated value
$6.32M
Buys / sales
0 / 21
Transactions reported in the same official filing
Issuer Transaction Traded Value
United Therapeutics Corp UTHR Exercise Jul 15, 2026 $232.65K
United Therapeutics Corp UTHR Sale Jul 15, 2026 $41.75K
United Therapeutics Corp UTHR Sale Jul 15, 2026 $62.88K
United Therapeutics Corp UTHR Sale Jul 15, 2026 $42.03K
United Therapeutics Corp UTHR Sale Jul 15, 2026 $21.1K
United Therapeutics Corp UTHR Sale Jul 15, 2026 $63.56K
United Therapeutics Corp UTHR Current Sale Jul 15, 2026 $147.61K
United Therapeutics Corp UTHR Sale Jul 15, 2026 $425.65K
United Therapeutics Corp UTHR Sale Jul 15, 2026 $85.31K
United Therapeutics Corp UTHR Sale Jul 15, 2026 $21.36K
United Therapeutics Corp UTHR Exercise Jul 15, 2026 $1.05M
United Therapeutics Corp UTHR Sale Jul 15, 2026 $25K
United Therapeutics Corp UTHR Sale Jul 15, 2026 $98.63K
United Therapeutics Corp UTHR Sale Jul 15, 2026 $106.21K
United Therapeutics Corp UTHR Sale Jul 15, 2026 $230.73K